Chase V

RESEARCH Published September 3, 2026 5-Amino-1MQ Research Guide 2026: NNMT Inhibition, NAD+ Pathways & Purity Compliance notice: This article is for laboratory research use only. It is not medical advice, not for human consumption, not for veterinary use, and is not intended to diagnose, treat, cure, or prevent any disease. 5-Amino-1MQ is not a peptide. It is a small-molecule research compound studied as an inhibitor of nicotinamide N-methyltransferase, or NNMT. That distinction matters...

The competition between tirzepatide and semaglutide defines the cutting edge of metabolic peptide research in 2026. Both are GLP-1 receptor agonists. Both produce dramatic weight loss and metabolic improvements. But tirzepatide brings a second mechanism, GIP receptor agonism, to the table, and clinical data suggests this dual approach may offer meaningful advantages. This comprehensive comparison examines the latest clinical trial data, mechanistic differences, real-world outcomes, side...

Proper peptide reconstitution is one of the most fundamental skills in peptide research. Whether you are working with BPC-157, semaglutide, growth hormone secretagogues, or any other lyophilized peptide, the reconstitution process directly impacts the stability, potency, and usability of your compound. Done incorrectly, you risk denaturing the peptide (destroying its biological activity) or introducing contamination that compromises your research. This guide covers everything from choosing...